Tesamorelin

$104.00

Tesamorelin is a synthetic, stabilized 44-amino-acid peptide analog of human growth hormone-releasing hormone (GHRH), marketed under the brand name Egrifta. It is the only FDA-approved GHRH analog for clinical use, indicated for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. The peptide binds to pituitary GHRH receptors to stimulate the pulsatile release of endogenous growth hormone, which subsequently increases insulin-like growth factor-1 (IGF-1) levels. This mechanism selectively targets visceral adipose tissue while preserving lean mass and supporting metabolic homeostasis.